Case report
Discussion
virus. Patients undergoing allogeneic bone marrow transplantation may require a longer duration of antiviral therapy The above case report demonstrates that HHV-6 is a possand have a higher incidence of relapse after antiviral therible etiologic agent in central nervous system infections in apy is stopped compared to patients undergoing autologous patients receiving bone marrow transplants. In this case bone marrow transplantation. Future studies designed to HHV-6 infection was confirmed by cerebropsinal fluid study these issues would be important in the quest for analysis by polymerase chain reaction for HHV-6 obtained improving the management of infectious complications in at the onset of neurological symptoms. Timely institution bone marrow transplant recipients, thus improving transof ganciclovir resulted in a significant recovery.
plant-related mortality and morbidity. The pathogenesis of HHV-6 is not yet fully delineated. In the recent past, our understanding of this virus has increased considerably along with its relation to the relReferences evance of its infection in a transplant recipient. What has not been clear is the role of HHV-6 in central nervous sys-IC 50 of acyclovir for HHV-6 is 100 mol/l a concentration The question of early detection and early treatment needs
